PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Health Catalyst, Inc. (HCAT)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINUS42225T1079
CUSIP42225T107
SectorHealthcare
IndustryHealth Information Services

Highlights

Market Cap$353.13M
EPS-$2.09
PE Ratio6.19
Revenue (TTM)$295.94M
Gross Profit (TTM)$135.56M
EBITDA (TTM)-$53.24M
Year Range$5.45 - $14.37
Target Price$11.93
Short %3.42%
Short Ratio2.95

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Health Catalyst, Inc.

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Health Catalyst, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-100.00%-50.00%0.00%50.00%December2024FebruaryMarchAprilMay
-83.30%
68.60%
HCAT (Health Catalyst, Inc.)
Benchmark (^GSPC)

S&P 500

Returns By Period

Health Catalyst, Inc. had a return of -29.37% year-to-date (YTD) and -47.93% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date-29.37%6.17%
1 month-6.03%-2.72%
6 months-11.26%17.29%
1 year-47.93%23.80%
5 years (annualized)N/A11.47%
10 years (annualized)N/A10.41%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
20245.51%-14.84%-9.50%-17.40%
2023-25.99%-4.14%28.97%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of HCAT is 13, indicating that it is in the bottom 13% of the market in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.


The Risk-Adjusted Performance Rank of HCAT is 1313
Health Catalyst, Inc.(HCAT)
The Sharpe Ratio Rank of HCAT is 1010Sharpe Ratio Rank
The Sortino Ratio Rank of HCAT is 1212Sortino Ratio Rank
The Omega Ratio Rank of HCAT is 1414Omega Ratio Rank
The Calmar Ratio Rank of HCAT is 1818Calmar Ratio Rank
The Martin Ratio Rank of HCAT is 99Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Health Catalyst, Inc. (HCAT) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


HCAT
Sharpe ratio
The chart of Sharpe ratio for HCAT, currently valued at -0.80, compared to the broader market-2.00-1.000.001.002.003.004.00-0.80
Sortino ratio
The chart of Sortino ratio for HCAT, currently valued at -1.11, compared to the broader market-4.00-2.000.002.004.006.00-1.11
Omega ratio
The chart of Omega ratio for HCAT, currently valued at 0.88, compared to the broader market0.501.001.500.88
Calmar ratio
The chart of Calmar ratio for HCAT, currently valued at -0.52, compared to the broader market0.002.004.006.00-0.52
Martin ratio
The chart of Martin ratio for HCAT, currently valued at -1.36, compared to the broader market-10.000.0010.0020.0030.00-1.36
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 1.97, compared to the broader market-2.00-1.000.001.002.003.004.001.97
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 2.84, compared to the broader market-4.00-2.000.002.004.006.002.84
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.34, compared to the broader market0.501.001.501.34
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.50, compared to the broader market0.002.004.006.001.50
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 7.61, compared to the broader market-10.000.0010.0020.0030.007.61

Sharpe Ratio

The current Health Catalyst, Inc. Sharpe ratio is -0.80. This value is calculated based on the past 12 months of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Health Catalyst, Inc. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00December2024FebruaryMarchAprilMay
-0.80
1.97
HCAT (Health Catalyst, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Health Catalyst, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%December2024FebruaryMarchAprilMay
-88.85%
-3.62%
HCAT (Health Catalyst, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Health Catalyst, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Health Catalyst, Inc. was 90.57%, occurring on Apr 16, 2024. The portfolio has not yet recovered.

The current Health Catalyst, Inc. drawdown is 88.85%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-90.57%Jun 9, 2021718Apr 16, 2024
-63.4%Aug 13, 2019149Mar 16, 2020216Jan 22, 2021365
-18.7%Apr 30, 202112May 17, 202115Jun 8, 202127
-14.93%Feb 10, 202133Mar 29, 202118Apr 23, 202151
-13.48%Aug 2, 20192Aug 5, 20194Aug 9, 20196

Volatility

Volatility Chart

The current Health Catalyst, Inc. volatility is 19.39%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%December2024FebruaryMarchAprilMay
19.39%
4.05%
HCAT (Health Catalyst, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Health Catalyst, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items